Effects of interferon-α, interferon-γ and cAMP on the transcriptional regulation of the serotonin transporter

被引:136
作者
Morikawa, O
Sakai, N
Obara, H
Saito, N
机构
[1] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Nada Ku, Kobe, Hyogo 657, Japan
[2] Kobe Univ, Sch Med, Dept Anaesthesiol, Kobe, Hyogo 657, Japan
关键词
5-HT; (5-hydroxytryptamine; serotonin); transporter; interferon; transcription; depression; mRNA;
D O I
10.1016/S0014-2999(98)00187-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We examined the effects of interferon-alpha and -gamma, which are known to have psychiatric side effects including depression, on the transcriptional regulation of the serotonin transporter and the uptake activity of the serotonin transporter in order to clarify the involvement of the serotonin transporter in the pathogenesis of interferon-induced depression. In human placental choriocarcinoma cells (BeWo cells), both messenger RNA (mRNA) for the serotonin transporter and the imipramine-sensitive uptake of serotonin were detected. The levels of serotonin transporter mRNA were increased by treatment with interferon-alpha and -gamma for 3 h. The increase in serotonin transporter mRNA elicited by the interferons was inhibited by treatment with actinomycin D, an inhibitor of transcription. Treatment with interferon-alpha or -gamma for 3-6 h, but not for 30 min, increased the uptake activity of the serotonin transporter. Treatment with dibutyryl cAMP (Dib-cAMP) which was reported to up-regulate the transcription of the serotonin transporter, also increased the mRNA levels and the activity of serotonin transporter in BeWo cells. The levels of serotonin transporter mRNA gradually increased after treatment with Dib-cAMP over 24 h, while the maximal increase in serotonin transporter mRNA elicited by the interferons was detected 3 h after the treatment. The level of serotonin transporter mRNA was increased both in the midbrain and adrenal glands of mice which were treated with interferons for 3 h. These results suggest that the interferon-induced psychiatric side effects arise through regulation of serotonin transporter transcription and that the transcriptional regulation of the serotonin transporter is a possible neurochemical mechanism of affective disorders. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 37 条
  • [1] ANDERSON DJ, 1985, J IMMUNOL, V135, P2498
  • [2] ACTIVATORS OF PROTEIN-KINASE-C DECREASE SEROTONIN TRANSPORT IN HUMAN PLATELETS
    ANDERSON, GM
    HORNE, WC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1137 (03) : 331 - 337
  • [3] Baldessarini R. J., 1980, PHARMACOL BASIS THER, P391
  • [4] Bennett WA, 1996, AM J REPROD IMMUNOL, V36, P285
  • [5] BLAKELY RD, 1994, J EXP BIOL, V196, P263
  • [6] CLONING AND EXPRESSION OF A FUNCTIONAL SEROTONIN TRANSPORTER FROM RAT-BRAIN
    BLAKELY, RD
    BERSON, HE
    FREMEAU, RT
    CARON, MG
    PEEK, MM
    PRINCE, HK
    BRADLEY, CC
    [J]. NATURE, 1991, 354 (6348) : 66 - 70
  • [7] BOSIN TR, 1989, J PHARMACOL EXP THER, V248, P67
  • [8] DEMONSTRATION OF EXTRANEURONAL 5-HYDROXYTRYPTAMINE ACCUMULATION IN BRAIN FOLLOWING MEMBRANE-PUMP BLOCKADE BY CHLORIMIPRAMINE
    CARLSSON, A
    JONASON, J
    LINDQVIST, M
    FUXE, K
    [J]. BRAIN RESEARCH, 1969, 12 (02) : 456 - +
  • [9] COOL DR, 1991, J BIOL CHEM, V266, P15750
  • [10] JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS
    DARNELL, JE
    KERR, IM
    STARK, GR
    [J]. SCIENCE, 1994, 264 (5164) : 1415 - 1421